| Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome A Lonardo, S Ballestri, G Marchesini, P Angulo, P Loria Digestive and Liver disease 47 (3), 181-190, 2015 | 779 | 2015 |
| Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and … S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ... Journal of gastroenterology and hepatology 31 (5), 936-944, 2016 | 720 | 2016 |
| Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes M Ricchi, MR Odoardi, L Carulli, C Anzivino, S Ballestri, A Pinetti, ... Journal of gastroenterology and hepatology 24 (5), 830-840, 2009 | 694 | 2009 |
| Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ... Hepatology 70 (4), 1457-1469, 2019 | 678 | 2019 |
| Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ... Digestive and Liver Disease 47 (12), 997-1006, 2015 | 508 | 2015 |
| NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ... Advances in therapy 34, 1291-1326, 2017 | 503 | 2017 |
| Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease S Ballestri, A Lonardo, S Bonapace, CD Byrne, P Loria, G Targher World journal of gastroenterology: WJG 20 (7), 1724, 2014 | 341 | 2014 |
| Nonalcoholic fatty liver disease and aging: epidemiology to management M Bertolotti, A Lonardo, C Mussi, E Baldelli, E Pellegrini, S Ballestri, ... World journal of gastroenterology: WJG 20 (39), 14185, 2014 | 316 | 2014 |
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016 | 231 | 2016 |
| Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD S Ballestri, A Lonardo, D Romagnoli, L Carulli, L Losi, CP Day, P Loria Liver International 32 (8), 1242-1252, 2012 | 209 | 2012 |
| Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications C Tana, S Ballestri, F Ricci, A Di Vincenzo, A Ticinesi, S Gallina, ... International journal of environmental research and public health 16 (17), 3104, 2019 | 178 | 2019 |
| The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine … S Ballestri, F Nascimbeni, D Romagnoli, A Lonardo Hepatology Research 46 (11), 1074-1087, 2016 | 151 | 2016 |
| Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology P Loria, G Marchesini, F Nascimbeni, S Ballestri, M Maurantonio, ... Atherosclerosis 232 (1), 99-109, 2014 | 145 | 2014 |
| Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease A Mantovani, S Ballestri, A Lonardo, G Targher Digestive diseases and sciences 61, 1246-1267, 2016 | 133 | 2016 |
| Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ... Metabolism 72, 57-65, 2017 | 132 | 2017 |
| Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV A Lonardo, S Ballestri, G Guaraldi, F Nascimbeni, D Romagnoli, S Zona, ... World journal of gastroenterology 22 (44), 9674, 2016 | 129 | 2016 |
| Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications S Ballestri, D Romagnoli, F Nascimbeni, G Francica, A Lonardo Expert review of gastroenterology & hepatology 9 (5), 603-627, 2015 | 125 | 2015 |
| Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen A Lonardo, LE Adinolfi, L Restivo, S Ballestri, D Romagnoli, E Baldelli, ... World journal of gastroenterology: WJG 20 (23), 7089, 2014 | 120 | 2014 |
| Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? L Carulli, S Ballestri, A Lonardo, F Lami, E Violi, L Losi, L Bonilauri, ... Internal and emergency medicine 8, 297-305, 2013 | 111 | 2013 |
| Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease A Lonardo, S Ballestri, G Targher, P Loria Expert review of gastroenterology & hepatology 9 (5), 629-650, 2015 | 94 | 2015 |
Amedeo LonardoMedicina Interna USL ModenaVerified email at ausl.mo.it
